CellSource Co., Ltd. (TSE: 4880)
Health Care · Life Sciences Tools & Services · JP
¥311.00
+1.30% today · -42.6% 1Y
CellSource Co., Ltd. (TSE: 4880) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $38.99M and employs 148 people.
Over the last twelve months the share price has lost 42.6%, trading between 294.00 and 594.00.
Tweenvest scores CellSource Co., Ltd. across four factors: quality 92/100, value 62/100, dividend 23/100. Its strongest factor is quality.
4880 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $38.99M
- Revenue (TTM)
- $23.39M
- P/E
- 88.08
- EPS
- 3.53
- Dividend yield
- 1.63%
- Beta (5Y)
- -0.01
- 52-week high
- ¥594.00
- 52-week low
- ¥294.00
- Avg volume (3M)
- —
- Shares outstanding
- 19.85M
- Employees
- 148
- Next earnings
- —
About CellSource Co., Ltd.
CellSource Co., Ltd. operates within both the regenerative medicine and consumer product sectors. Among its offerings is Signalift, an anti-aging solution. The company, which was established in 2015, is headquartered in Tokyo, Japan.
- ISIN
- JP3423580004
- Founded
- 2015
- Listed since
- Oct 29, 2019
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cryosite LimitedASX: CTE | $41.04M | AU$1.21 | +4.78% |
| Precision System Science Co., Ltd.TSE: 7707 | $40.24M | ¥232.00 | +9.43% |
| WDB coco Co., Ltd.TSE: 7079 | $39.64M | ¥2,610.00 | -0.46% |
| Cyfuse Biomedical K.K.TSE: 4892 | $39.14M | ¥622.00 | -5.04% |
| Arch Biopartners Inc.OTCPK: ACHF.F | $38.26M | $0.56 | -1.30% |
| Harvard Bioscience, Inc.NasdaqCM: HBIO | $37.51M | $8.49 | +3.03% |
| ORIENT BIO Inc.KOSE: A002630 | $36.12M | ₩1,638.00 | -0.12% |
| P&K Skin Research Center Co., Ltd.KOSDAQ: A347740 | $36.09M | ₩1,680.00 | +1.82% |
Figures last refreshed Oct 11, 2026.